CNS Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
368
across all filing types
Latest filing
2021-04-30
Annual Report
Country
US
United States of America
Listing
US
CNSP
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company's primary focus is on glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. Its lead drug candidate, Berubicin, is an anthracycline designed to cross the blood-brain barrier, a significant challenge in treating CNS tumors. The company's technology aims to enable therapeutics to penetrate the brain and directly target tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| AMENDMENT #2 TO THE ANNUAL REPORT | 2021-04-30 | English | |
| FORM 8-K | 2021-03-17 | English | |
| FORM 8-K | 2021-02-25 | English | |
| AMENDED ANNUAL REPORT | 2021-02-16 | English | |
| CURRENT REPORT | 2021-02-12 | English | |
| PROSPECTUS SUPPLEMENT | 2021-02-12 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
14 filings
| |||||
| 13091231 | AMENDMENT #2 TO THE ANNUAL REPORT | 2021-04-30 | English | ||
| 13091233 | FORM 8-K | 2021-03-17 | English | ||
| 13091237 | FORM 8-K | 2021-02-25 | English | ||
| 13091243 | AMENDED ANNUAL REPORT | 2021-02-16 | English | ||
| 13091246 | CURRENT REPORT | 2021-02-12 | English | ||
| 13091235 | PROSPECTUS SUPPLEMENT | 2021-02-12 | English | ||
| 13091251 | FORM 10-K | 2021-02-12 | English | ||
| 13091239 | Director's Dealing 2021 | 2021-02-09 | English | ||
| 13091238 | Director's Dealing 2021 | 2021-02-09 | English | ||
| 13091240 | Regulatory Filings 2021 | 2021-02-04 | English | ||
| 13091241 | Regulatory Filings 2021 | 2021-02-01 | English | ||
| 13091253 | Regulatory Filings 2021 | 2021-02-01 | English | ||
| 13091242 | FORM S-3 REGISTRATION STATEMENT | 2021-01-27 | English | ||
| 13091289 | CURRENT REPORT | 2021-01-07 | English | ||
|
2020
1 filing
| |||||
| 13091256 | FORM 8-K | 2020-12-28 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CNS Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35399/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35399 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35399 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35399 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35399}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CNS Pharmaceuticals, Inc. (id: 35399)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.